[Ip-health] WHO Expert Working Group on R&D Financing

[Judit Rius Sanjuan]

The WHO PHI secretariat has created a website for the first meeting of
the WHO Expert Working Group on R&D Financing, with agenda and
presentations. Everything is available here:  http://www.who.int/phi/1stmee=
ting/en/index.html

AGENDA:

WHO EXPERT WORKING GROUP ON R&D* FINANCING
Salle B, WHO headquarters
Geneva, 12-14 January 2009

AGENDA

Monday, 12 January 2009

09:30-10:30   Opening Session

    Welcome by Dr Margaret Chan, Director-General
    Election of Chair, Vice-Chair and Rapporteurs
    Introductions (Experts)

10:30-11:00  Coffee break

11:00-12:30  Session 2: Setting the Stage

=E2=80=A2 The global strategy and plan of action on public health,
innovation and intellectual property
=E2=80=A2 Method of work and expected outputs of Expert Working Group

12:30-14:00  Lunch break

14:00-17:30  Session 3: Current Financing of R&D=E2=88=97
Presentations and discussions on:

=E2=80=A2 Monitoring financial flows in health research 2008
(Prof. Stephen Matlin, Executive Director, Global Forum for
Health Research)
=E2=80=A2 R&D financing by Bill and Melinda Gates Foundation
(Dr Neil McDonnell, Chief of Staff, Global Health Program)
=E2=80=A2 R&D financing by research-based industry
(Ms Alicia Greenidge, Director-General, International
Federation of Pharmaceutical Manufacturers & Associations)
=E2=80=A2 Global funding of innovation for neglected diseases
(G-FINDER initiative - Ms Anne-Laure Ropars, The George
Institute for International Health)

18:00-20:00  Reception

Tuesday, 13 January 2009

9:00-12:30   Session 3 (cont.)

followed by

Session 4: Coordination of R&D*

Review of some existing models for R&D coordination, including:

=E2=80=A2 International AIDS Vaccine Initiative
(Dr Seth Berkley, President & CEO, International AIDS Vaccine
Initiative)
=E2=80=A2 STOP TB New Tools Working Groups
(Dr Marcos Espinal, Executive Secretary, Stop TB Partnership
Secretariat)
=E2=80=A2 Partnerships for Product Development
(Dr Robert Ridley, Director, Special Programme for Research
and Training in Tropical Diseases)
=E2=80=A2 Initiative for Vaccine Research
(Dr Marie-Paule Kieny, Director, Initiative for Vaccine
Research)
=E2=80=A2 ESSENCE Initiative
(Prof. Hannah Akuffo, Manager, ESSENCE Secretariat, Special
Programme for Research and Training in Tropical Diseases)
=E2=80=A2 Consultative Group on International Agricultural Research
(As an example from a non-health sector) (to be confirmed)

12:30-14:00  Lunch break

14:00-17:30  Session 4 (cont.)

Wednesday, 14 January 2009

9:00-12:30  Session 5: Conclusions for Sessions 3 and 4 and any
Relevant Follow-
up Action

Session 6: Future Meetings and Next Steps
(including discussions on procedures to solicit inputs/proposals from
Member States)


Judit Rius Sanjuan
Attorney
Knowledge Ecology International / Essential Information
www.keionline.org / www.cptech.org
Phone: +1.202 332 2670, ext 18